Heparin-coated circuits reduce myocardial injury in heart or heart-lung transplantation: a prospective, randomized study
- 1 October 1999
- journal article
- clinical trial
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 68 (4) , 1230-1235
- https://doi.org/10.1016/s0003-4975(99)00701-8
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Inflammatory Response to Cardiopulmonary BypassChest, 1997
- Heparin coating of extracorporeal circuits inhibits contact activation during cardiac operationsThe Journal of Thoracic and Cardiovascular Surgery, 1997
- Clinical evaluation of Duraflo® II heparin treated extracorporeal circulation circuits (2nd version) The European working group on heparin coated extracorporeal circulation circuitsEuropean Journal of Cardio-Thoracic Surgery, 1997
- Cytokine Responses to Cardiopulmonary Bypass: Lessons Learned From Cardiac TransplantationThe Annals of Thoracic Surgery, 1997
- Human cytokine responses to cardiac transplantation and coronary artery bypass graftingThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Steroid administration in heart and heart—lung transplantation: Is the timing adequate?The Annals of Thoracic Surgery, 1996
- Influence of Duraflo II heparin-treated extracorporeal circuits on the systemic inflammatory response in patients having coronary bypassThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypassThe Annals of Thoracic Surgery, 1995
- Cardiac troponin I. A marker with high specificity for cardiac injury.Circulation, 1993
- Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypassThe Annals of Thoracic Surgery, 1993